Latest Transformation News

Page 3 of 432
Skydance delivered US$7.0 billion in pre-acquisition third-quarter revenue, but its first post-Warner Bros. Discovery update paired streaming growth with a warning on the film slate and a heavily leveraged balance sheet. The company is targeting at least US$6 billion in annualised synergies within three years.
Victor Sage
Victor Sage
10 Nov 2026
Virgin Australia has reaffirmed its FY27 outlook, with first-half underlying EBIT expected to remain broadly in line with the prior year despite elevated fuel, airport and labour costs. The airline is trimming domestic capacity while maintaining 6% to 8% RASK growth and committing up to $1 billion to fleet and other capital investment.
Victor Sage
Victor Sage
9 Nov 2026
Delorean has reached Financial Close on its $62.1 million NSW1 Horsley Park bioenergy facility, activating $30.5 million of government grants and a 25-year Brickworks gas supply agreement. Procurement can now begin, with construction targeted for early 2027, although Tanarra’s debt documentation and the project’s funding mix still warrant attention.
Victor Sage
Victor Sage
9 Nov 2026
Service Stream will acquire Programmed for $975 million and raise $475 million in new equity, targeting more than 20% pro forma FY27 EPS-A accretion. The deal would sharply increase scale, but also leaves shareholders facing dilution, higher debt and a substantial integration task.
Victor Sage
Victor Sage
9 Nov 2026
Smartgroup reported a 31% year-on-year increase in Q3 novated leasing settlements and maintained its CY2026 NPATA guidance at $92 million to $94 million. The company is accelerating reinvestment in the second half as it builds towards a targeted mid-40s EBITDA margin in 2027.
Claire Turing
Claire Turing
9 Nov 2026
ANZ Group Holdings reported a 31% rise in FY26 cash profit to A$7.591 billion, helped by sharp cost reductions and stronger Australian banking performance. The 83-cent final dividend was maintained, but rising impairments, weaker New Zealand earnings and heavier capital demands leave the next phase of the turnaround less straightforward.
Victor Sage
Victor Sage
9 Nov 2026
Clinuvel has outlined a multi-year expansion from peptide therapeutics into polymers, long-acting injectables, devices and digital health, backed by A$220 million of planned FY2027-FY2030 spending. The strategy comes with a near-term setback: first patient treatment in the CUV107 vitiligo study has been delayed to February 2027.
Victor Sage
Victor Sage
6 Nov 2026
Riversgold has locked in $1.55 million from sophisticated and professional investors to fund its E25/594 acquisition from Black Cat Syndicate. The deal would expand the Kalgoorlie-Northern Zone Project nearly 15-fold, but more than 258 million new shares will be issued across two tranches.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Monster Beverage delivered a strong third quarter, with sales rising 16.7% to US$2.56 billion and international revenue climbing 28.1%. The trade-off was narrower margins as aluminium, freight, fuel, marketing and transformation costs increased.
Victor Sage
Victor Sage
6 Nov 2026
Enero Group delivered stronger FY26 earnings and a $24.5 million net cash position, but its new financial year has opened with group EBITDA down 28% as Hotwire and BMF absorb restructuring and client losses. Orchard’s record quarter and rising AI revenue provide the counterweight, but execution remains the central test.
Victor Sage
Victor Sage
6 Nov 2026
Southern Company delivered a stronger third quarter, with reported earnings up 19.6% and revenue rising 13% as warmer weather, customer growth and large commercial demand lifted electricity sales. The result also carries a growing list of costs tied to wind repowering, debt transactions and regulatory issues at Nicor Gas.
Maxwell Dee
Maxwell Dee
6 Nov 2026
Zoetis lifted its full-year adjusted earnings outlook after a mixed third quarter, but US companion animal revenue fell 8% amid price sensitivity, competition and generic pressure. The animal health group also reported an 18% drop in GAAP net income and a US$89 million impairment charge.
Ada Torres
Ada Torres
5 Nov 2026

Browse the archive

Full archive